We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Key Modulator of Inflammation Identified

By Biotechdaily staff writers
Posted on 04 Aug 2004
Researchers studying the molecular biology of inflammation and autoimmune disease have found that a protein called ELKS is an essential regulatory element of the IkappaB kinase (IKK) complex, which in turn modulates the activity of nuclear factor-kappa B (NF-kB), a family of transcription factors that plays a seminal role in inflammation, apoptosis, development, and cancer.

Investigators at the Salk Institute (La Jolla, CA, USA; www.salk.edu) reported in the June 25, 2004, issue of Science that silencing ELKS expression by RNA interference blocked induced expression of NF-kB target genes, including the NF-kB inhibitor IkBalpha and proinflammatory genes such as cyclo-oxygenase 2 and interleukin 8. More...
Cells lacking ELKS activity were also not protected from apoptosis in response to cytokines.

"NF-kB is a major cell-survival signaling molecule, but it needs to be induced,” said senior author Dr. Inder Verma, a professor of molecular biology at the Salk Institute. "It normally is found in an inactive form in nearly all cells, but in response to external signals it encourages inflammatory responses and only triggers those responses when it receives the right messages. ELKS is one of the essential components of the complex, without which NF-kB can not function.”



Related Links:
Salk Institute

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.